Vitamin Shoppe survey finds most adults take vitamins or supplements
NORTH BERGEN, N.J. — A survey conducted on behalf of The Vitamin Shoppe and released Wednesday found that 60% of adults currently take a vitamin or supplement.
Of those who take vitamins, the survey results reported that more than 70% of respondents said they feel more confident about their health when they are taking a vitamin. Multivitamins are the most popular supplement, with 75% of respondents reportedly regularly taking the supplement. Other top supplements by those who take vitamins were: vitamin D (52%), vitamin C (49%), calcium (45%), B vitamins (43%), fish oil (42%) and iron (25%).
Starting on a vitamin regimen was not an impulse decision, Vitamin Shoppe found. Nearly half (46%) began taking a vitamin based on the recommendation of an expert, one-third (34%) wanted to improve their health altogether and about 1-in-10 (9%) wanted to feel better about themselves.
The Vitamin Shoppe survey found that only 4-in-10 (38%) of moms and dads take a daily vitamin, compared with 56% of nonparents. Even fewer parents pass on this habit to their children. Only one-third (34%) of kids get a daily vitamin.
For those that do not take supplements, 43% feel they do not need vitamins with a balanced diet, 22% think they would never remember to take them, and others feel vitamins are too expensive (9%).
The survey was conducted by Wakefield Research on behalf of The Vitamin Shoppe, and polled 1,000 U.S. adults on their vitamin and supplement habits.
CRN meets with freshmen offices in House, Senate
WASHINGTON — The Council for Responsible Nutrition on Wednesday announced the association has reached “a milestone of meetings,” having met with all 112 freshmen offices in the House and Senate within the first 60 legislative days of the 112th Congress.
“Incoming members face a daunting challenge of quickly getting up to speed on a myriad of issues and industries,” CRN VP government relations Mike Greene said. “Like so many other industries, the dietary supplement industry faces complex legal and regulatory challenges that require a focused and articulate education program if we hope to find allies on Capitol Hill. Our goal is to develop open lines of communication with legislators and to serve as a resource on potential legislative issues.”
The meetings with the new offices focused on the role of dietary supplements in good health, their value to healthcare savings and the economy in general, and the extent of the existing regulation for supplements under the Dietary Supplement Health and Education Act, CRN stated.
“Now that we have been able to meet with so many new faces in Congress and introduce CRN and the industry, we’ll adjust our approach to reflect specific requests and proposals, such as urging support for specific legislation, co-signing letters or joining the Dietary Supplement Caucus,” Greene added. “CRN’s annual Day on the Hill in June will provide our member companies an opportunity to meet with individual congressional offices and share their concerns and ideas, not just as representatives of the dietary supplement industry, but also as employers, economic contributors and constituents.”
Schiff buys into probiotic business
SALT LAKE CITY — Schiff Nutrition on Tuesday announced its $40 million acquisition from Ganeden Biotech of the worldwide exclusive rights to use the probiotic technology GanedenBC30 in the over-the-counter and dietary supplement space, along with the brands Sustenex and Digestive Advantage, under which GanedenBC30 currently is sold.
"By acquiring the rights to the leading probiotics technology, we have entered a new, rapidly expanding category that creates accretive growth opportunities,” Schiff Nutrition president and CEO Tarang Amin said. “We intend to leverage this enviable technology and grow the Sustenex and Digestive Advantage lines. In addition, we plan to capitalize on Schiff’s brand marketing know-how, provide incremental marketing investment and use our well-established customer relationships to increase distribution.”
The assets and brands acquired from Ganeden generated net revenue of approximately $17 million for the year ended Dec. 31.
The probiotics category is growing at more than 20% on an annualized basis, according to the Nutrition Business Journal, as cited by Schiff.